Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302243 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ilary Riedmiller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Centre for translational Medicine and Parasitology, Faculty of Health and Medical Sciences, University of …. Hauptthemen laut MEDLINE: Protozoan Proteins, Vaccines, Virus-Like Particle, Endothelial Protein C Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lundbeck Foundation, Danmarks Frie Forskningsfond, Kirsten og Freddy Johansens Fond.
Abstract (Originalsprache)
The sequestration of Plasmodium falciparum- infected erythrocytes to the host endothelium is central to the pathogenesis of malaria. The sequestration is mediated by the parasite´s diverse Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants, which bind select human receptors on the endothelium. Severe malaria is associated with PfEMP1 binding human endothelial protein C receptor (EPCR) via their CIDRα1 domains. Antibodies binding and inhibiting across the sequence diverse CIDRα1 domains are likely important in acquired immunity against severe malaria. In this study, we explored if immunization with AP205 bacteriophage capsid-virus-like particles (cVLPs) presenting a mosaic of diverse CIDRα1 protein variants would stimulate broadly reactive and inhibitory antibody responses in mice. Three different mosaic cVLP vaccines each composed of five CIDRα1 protein variants with varying degrees of sequence conservation of residues at and near the EPCR binding site, were tested. All mosaic cVLP vaccines induced functional antibodies comparable to those induced by matched cocktails of cVLPs decorated with the single CIDRα1 variant. No broadly reactive responses were observed. However, the vaccines did induce some cross-reactivity and inhibition within the CIDRα1 subclasses included in the vaccines, demonstrating potential use of the cVLP vaccine platform for the design of multivalent vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Centre for translational Medicine and Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- AdaptVac Aps, Copenhagen N, Denmark.
ORCID-Profile: Ilary Riedmiller, Thomas Lavstsen
Förderung
- Lundbeck Foundation
- Danmarks Frie Forskningsfond
- Kirsten og Freddy Johansens Fond
Zitieren
APA
Riedmiller, I., Fougeroux, C., Jensen, R. W., Kana, I. H., Sander, A. F., Theander, T. G., Lavstsen, T., & Turner, L. (2024). Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1. PLOS ONE. https://doi.org/10.1371/journal.pone.0302243
Vancouver
Riedmiller I, Fougeroux C, Jensen RW, Kana IH, Sander AF, Theander TG, et al. Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1. PLOS ONE. 2024. doi:10.1371/journal.pone.0302243
BibTeX
@article{Riedmiller2024,
author = {Riedmiller, Ilary and Fougeroux, Cyrielle and Jensen, Rasmus W and Kana, Ikhlaq H and Sander, Adam F and Theander, Thor G and Lavstsen, Thomas and Turner, Louise},
title = {Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302243}
}
EUVIMED